InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Herve Brailly, Président. Insider active across 1 company, notably Innate Pharma. In total, 25 reports have been recorded. Breakdown: 0 buy · 21 sells. Total volume traded: €451k. Activity tracked since 5 February 2021. The latest transaction was disclosed on 17 June 2022 (Cession). Regulator: AMF. The full history is accessible without signup.
Companies and markets linked to Herve Brailly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
10,000 shares@ €2.39732.2% of flowActionEuronext ParisISIN FR00103314212022DD850530
10,000 shares@ €2.551734.2% of flowActionEuronext ParisISIN FR00103314212022DD850535
10,000 shares@ €2.505533.6% of flowActionEuronext ParisISIN FR00103314212022DD849422
10,000 shares@ €2.47952.4% of flowActionEuronext ParisISIN FR00103314212022DD847925
10,000 shares@ €2.912.8% of flowActionEuronext ParisISIN FR00103314212022DD847585
10,000 shares@ €2.912.8% of flowActionEuronext ParisISIN FR00103314212022DD846559
7,000 shares@ €2.8922.0% of flowActionEuronext ParisISIN FR00103314212022DD846557
10,000 shares@ €2.9232.8% of flowActionEuronext ParisISIN FR00103314212022DD846558
30,000 shares@ €4.4512.9% of flowActionHors plateforme de négociationISIN FR00103314212022DD817969
10,000 shares@ €5.505.3% of flowActionEuronext ParisISIN FR00103314212021DD773273
130,000 shares@ €2.0425.6% of flowOption d'achatEuronext ParisISIN FR00103314212021DD767831
50,000 shares@ €2.049.8% of flowOption d'achatEuronext ParisISIN FR00103314212021DD766561
49,095 shares@ €3.2515.4% of flowActionDonation - opération hors marché ne dionnant pasISIN FR00103314212021DD760059
1,405 shares@ €3.77830.5% of flowActionEuronext ParisISIN FR00103314212021DD738884
3,500 shares@ €3.76951.3% of flowActionEuronext ParisISIN FR00103314212021DD738882
3,500 shares@ €3.73641.3% of flowActionEuronext ParisISIN FR00103314212021DD738881
3,500 shares@ €3.77531.3% of flowActionEuronext ParisISIN FR00103314212021DD738337
3,500 shares@ €3.82941.3% of flowActionEuronext ParisISIN FR00103314212021DD738336
4,000 shares@ €3.80171.5% of flowActionEuronext ParisISIN FR00103314212021DD738335
3,500 shares@ €3.67131.2% of flowActionEuronext ParisISIN FR00103314212021DD738334
3,500 shares@ €4.05861.4% of flowActionEuronext ParisISIN FR00103314212021DD732509
5,100 shares@ €3.96592.0% of flowActionEuronext ParisISIN FR00103314212021DD732508
3,500 shares@ €4.05861.4% of flowActionEuronext ParisISIN FR00103314212021DD731721
7,400 shares@ €3.97222.8% of flowActionEuronext ParisISIN FR00103314212021DD731720
6,400 shares@ €3.79132.3% of flowActionEuronext ParisISIN FR00103314212021DD731719
25 of 25 declarations
About Herve Brailly
HERVE BRAILLY is Président and President du conseil de surveillance of Innate Pharma (XPAR). He has 25 filings, and across the 25 sampled filings between 2021-12-08 and 2022-07-06, the reported sell amount is EUR 450558 and the modal transaction nature is Cession.
